Mammalian multipotent stem cells and compositions, methods...

Details Mammalian multipotent stem cells and compositions, methods... Mammalian multipotent stem cells and compositions, methods...

2003-01-14

2009-12-22

Gamett, Daniel C (Department: 1647)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C435S377000, C435S368000, C435S372000, C435S373000, C435S366000, C435S325000, C424S093700

Reexamination Certificate

active

07635467

ABSTRACT:
This invention provides methods for preparing novel mammalian multipotent stem cells (MSCs), compositions thereof, and methods of preparing and administering the cells.

REFERENCES:
patent: 4959368 (1990-09-01), Awaya
patent: 5104650 (1992-04-01), Ralph et al.
patent: 5411883 (1995-05-01), Boss et al.
patent: 5589376 (1996-12-01), Anderson et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5766948 (1998-06-01), Gage et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5925567 (1999-07-01), Kraus et al.
patent: 5968829 (1999-10-01), Carpenter
patent: 5976523 (1999-11-01), Awaya et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6013521 (2000-01-01), Gage et al.
patent: 6020197 (2000-02-01), Gage et al.
patent: 6040180 (2000-03-01), Johe
patent: 6090624 (2000-07-01), Greenwood et al.
patent: 6117675 (2000-09-01), van der Kooy et al.
patent: 6254865 (2001-07-01), Freed et al.
patent: 6284245 (2001-09-01), Edge
patent: 6306575 (2001-10-01), Thomas et al.
patent: 6368854 (2002-04-01), Weiss et al.
patent: 6497872 (2002-12-01), Weiss et al.
patent: 6638501 (2003-10-01), Bjornson et al.
patent: 6670397 (2003-12-01), Baranowitz
patent: 6787355 (2004-09-01), Miller et al.
patent: 6808702 (2004-10-01), Pasricha et al.
patent: 6824973 (2004-11-01), Tang et al.
patent: 6833268 (2004-12-01), Green et al.
patent: 2001/0038836 (2001-11-01), During et al.
patent: 2002/0091133 (2002-07-01), Taylor
patent: 2002/0142457 (2002-10-01), Umezawa et al.
patent: 2002/0146821 (2002-10-01), Sanchez-Ramos et al.
patent: 2002/0168350 (2002-11-01), Brazelton et al.
patent: 2002/0168765 (2002-11-01), Prockop et al.
patent: 2003/0053992 (2003-03-01), Rader et al.
patent: 2003/0059868 (2003-03-01), Greenwood et al.
patent: 2003/0118566 (2003-06-01), Neuman et al.
patent: 2003/0139410 (2003-07-01), Sugaya et al.
patent: 2003/0148513 (2003-08-01), Sugaya et al.
patent: 2003/0219898 (2003-11-01), Sugaya et al.
patent: 2004/0034049 (2004-02-01), Okawa et al.
patent: 2004/0103448 (2004-05-01), Bjorklund
patent: 2004/0106197 (2004-06-01), Okano et al.
patent: 2005/0169897 (2005-08-01), Snyder et al.
patent: 2005/0181503 (2005-08-01), Goldman et al.
patent: 0 192 783 (1986-09-01), None
patent: 0 305 184 (1989-03-01), None
patent: 0 612 746 (1994-08-01), None
patent: 0 648 495 (1995-04-01), None
patent: 64-040483 (1989-02-01), None
patent: 64-079183 (1989-03-01), None
patent: 1-139572 (1989-06-01), None
patent: 7-90002 (1995-04-01), None
patent: 8-502172 (1996-03-01), None
patent: 8-325268 (1996-12-01), None
patent: 9-507747 (1997-08-01), None
patent: 9-295946 (1997-11-01), None
patent: 9-328435 (1997-12-01), None
patent: 10-504308 (1998-04-01), None
patent: 2001-504123 (2001-03-01), None
patent: 2001-526884 (2001-12-01), None
patent: 2002-500624 (2002-01-01), None
patent: 2002-502858 (2002-01-01), None
patent: 2002-518990 (2002-07-01), None
patent: WO 87/04928 (1987-08-01), None
patent: WO 89/01938 (1989-03-01), None
patent: WO 93/01275 (1993-01-01), None
patent: WO 94/09119 (1994-04-01), None
patent: WO 94/10292 (1994-05-01), None
patent: WO 94/16718 (1994-08-01), None
patent: WO 95/13364 (1995-05-01), None
patent: PCT/CA95/00637 (1995-11-01), None
patent: WO 96/04789 (1996-02-01), None
patent: WO96/15226 (1996-05-01), None
patent: WO 98/22127 (1998-05-01), None
patent: WO 98/32457 (1998-07-01), None
patent: WO 99/11758 (1999-03-01), None
patent: WO 99/32606 (1999-07-01), None
patent: WO 99/40107 (1999-08-01), None
patent: WO 99/43286 (1999-09-01), None
patent: PCT/US99/27613 (1999-11-01), None
patent: WO00/29550 (2000-05-01), None
patent: WO 00/69448 (2000-11-01), None
patent: WO 01/11011 (2001-02-01), None
patent: WO 01/34167 (2001-05-01), None
patent: WO 01/53461 (2001-07-01), None
patent: WO 01/59072 (2001-08-01), None
patent: WO 02/064748 (2002-08-01), None
patent: PCT/US03/01254 (2003-07-01), None
patent: WO03/060085 (2003-07-01), None
patent: WO 2005/009359 (2005-02-01), None
Coleman et al., Developmental Biology (1969), 19(6): 527-548 Abstract, Caplus Accession No. 1969:420164.
Kidson et al., Experimental Cell Research, vol. 188, Issue 1, May 1990, pp. 36-41, Abstract.
Kopen et al., Proc. Nat'l. Acad. Sci..vol. 96, Issue 19, 10711-10716, Sep. 14, 1999.
Fukuyama et al., “A synthesized pyrimidine compound, MS-818, promotes walking function recovery from crush injury of the sciatic nerve through its indirect stimulation of Schwann cells”Restorative Neurology and Neuroscience17 (2000) 9-16.
Yoshikawa et al., “The Effect of MS-818, Newly Synthesized Pyrimidine Compound, on Fracture Repair”Kobe J. Med. Sci.46:265-282 (Dec. 2000).
Itoh et al., “The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nerves”Restorative Neurology and Neuroscience14:265-273 (1999).
Jiang et al., “The effect of MS-818, a pyrimidine compound, on the regeneration of peripheral nerve fibers of mice after a crush injury”Acta Neuropathol90:130-134 (1995).
Yasuhara et al., “The Neurotrophic Pyrimidine Heterocyclic Compound MS-818 Promotes the Angiogenesis Induced by Basic FGF”Int. J. Clin. Pharm. Res.XV(5/6) 167-174 (1995).
Koyama et al., “Neurotropic Pyrimidine Heterocyclic Compounds. II. Effects of Novel Neurotropic Pyrimidine Derivatives on Astrocytic Morphological Differentiation”Biol. Pharm. Bull.20(2) 138-141 (1997).
Torigoe et al., “A newly synthesized neurotropic pyrimidine compound, MS-818, may activate migratory Schwann cells in peripheral nerve regeneration”Brain Research787(1998) 337-340.
Watanabe et al., “A Neurotrophic Pyrimidine Compound, MS-818, Enhances EGF-Induced Restoration of Gastric Epithelial Wounds in Vitro”J. Clin. Gastroenterol1988:27(Suppl. 1)S105-S109.
Sugiyama et al., “Acceleration by MS-818 of Early Muscle Regeneration and Enhanced Muscle Recovery after Surgical Transection”Muscle&NerveFeb. 2002 218-229.
Alvarez-Buylia et al., 1997,J. Neurobiology 33: 585-601.
Benninger et al., 2000,Brain Pathol. 10: 330-341.
Blakemore et al., 1991,Trends Neurosci. 14: 323-327.
Blakemore et al., 2000,Cell Transplant. 9: 289-294.
Brannen et al., 2000,Neuroreport 11: 1123-8.
Carpenter et al., 1999,Experimental Neurology 158: 265-278.
Cattaneo et al., 1996,Mol. Brain Res. 42: 161-66.
Doetsch et al., 1999,Cell 97: 703-16.
Eckenstein et al., 1994,Biochem. Pharmacol. 47: 103-110.
Fricker et al., 1999,J. Neurosci. 19: 5990-6005.
Frölichsthal-Schoeller et al., 1999,NeuroReport 10: 345-351.
Gonzalez et al., 1995,Brain Res. 701: 201-226.
Gould et al., 1999,Science 286: 548-552.
Hatton et al., 1992,Glia 5: 251-258.
Johansson et al., 1999,Cell 96: 25-34.
Kurimoto et al., 2001, Neurosci Let. 306: 57-60.
Lundberg et al., 1996,Exp. Neurol. 139: 39-53.
Nishida et al., 2000, Invest Ophthalmol Vis Sci 41: 4268-74.
Pundt et al., 1995,Brain Res. 695: 25-36.
Qu et al., 2001,Neuroreport 12: 1127-32.
Rosser et al., 2000,Eur. J. Neurosci. 12: 2405-2413.
Rubio et al., 2000,Mol. Cell. Neurosci. 16: 1-13.
Svendsen et al., 1998,J. Neurosci. Methods 85: 141-152.
Svendsen et al., 1999,Brain Pathol. 9: 499-51.
Warfvinge et al., 2001, Exp. Neurol. 169: p. 1-12.
Williams et al., 1996,J. Comp. Neurol. 370: 147-158.
Daadi et al Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. The Journal of Neuroscience. Jun. 1, 1999, vol. 19, No. 11, pp. 4484-4497.
Murphy et al. Neural Stem Cells. Journal of Investigative Dermatology Symposium Proceedings. Aug. 1997, vol. 2, No. 1, pp. 8-13.
Mazurova et al. New therapeutic approaches for the treatment of Huntington's disease. Acta Medica 2001, vol. 44, No. 4, pp. 119-123.
Memberg et al. Proliferation, differentiation and survival of rat sensory neuron precursors in vitro require specific trophic factors. Molecular and Cellular Neuroscience. Aug. 1995, vol. 6, No. 4, pp. 323-335.
Andrews et al. TNFa potentiates IFN g-induced cell death in oligodendrocyte progenitors. Journal of Neuroscience Research. Dec. 1998, vol. 54,

Affiliated with

Also associated with

Rating

Mammalian multipotent stem cells and compositions, methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian multipotent stem cells and compositions, methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian multipotent stem cells and compositions, methods... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4138843